NIH-funded research R21 grant

Investigating brain cell dysfunction in Fragile X Syndrome

Official title: Multilevel Analysis of Cortical Interneuron Dysfunction in Fragile X Syndrome

Funded at Columbia University Health Sciences · NIH-10746852 · Data updated 2026-11-12

This study is looking at how specific brain cells work in people with Fragile X Syndrome, using a mouse model to help understand their role in the condition and related issues like autism, with the hope of finding new ways to help.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startDecember 1, 2022
Project endNovember 30, 2025
Funding year2024
Award (this year)$200,442
NIH project number5R21MH131947-02
Project IDNIH-10746852 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with Fragile X Syndrome or those exhibiting autism-like features associated with the condition.

Less likely to help

Patients without a diagnosis of Fragile X Syndrome or related neurodevelopmental disorders may not benefit from this research.

What this research studies

This research focuses on understanding how certain brain cells, known as cortical interneurons, function in individuals with Fragile X Syndrome (FXS). By studying a mouse model of FXS, researchers aim to uncover the role of these interneurons in the condition's development and how they may contribute to related disorders like autism. The study employs innovative techniques to analyze the number, distribution, and connections of these cells, which are often overlooked in FXS research. The findings could provide insights into the underlying mechanisms of FXS and potentially lead to new therapeutic strategies.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment options for individuals with Fragile X Syndrome and related neurodevelopmental disorders.

How similar studies have gone: While the specific focus on cortical interneurons in FXS is relatively novel, previous research has shown success in studying synaptic defects in related neurodevelopmental disorders.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Au, Edmund — Columbia University Health Sciences
  • Study coordinator: Au, Edmund

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.